Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Mikus

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Pharmacology|April 28, 2025
Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteersAlexander Lenard, Simon A Hermann, Felicitas Stoll, et al.
Paediatric Drugs|March 18, 2017
Erratum to: Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot StudyJanelle D Vaughns, Victoria C Ziesenitz, Elaine F Williams, et al.
Paediatric Drugs|February 27, 2017
Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot StudyJanelle D Vaughns, Victoria C Ziesenitz, Elaine F Williams, et al.
Clinical Pharmacokinetics|August 1, 2025
Author's Reply to Helsby and Hannam: 'Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights'Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, et al.
British Journal of Clinical Pharmacology|March 18, 2006
Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individualsChristiane Hesse, Steffen P Luntz, Heike Siedler, et al.
Drugs & Aging|January 13, 2023
Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory StudyAnnette Eidam, Julian Marji, Petra Benzinger, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 19, 2019
Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal filmKlara Kiene, Noriyuki Hayasi, Jürgen Burhenne, et al.
Trials|July 1, 2020
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trialFelicitas Stoll, Antje Blank, Gerd Mikus, et al.
Clinical Pharmacokinetics|November 21, 2019
Midazolam Pharmacokinetics in Obese and Non-obese Children and AdolescentsChristina Gade, Eva Sverrisdóttir, Kim Dalhoff, et al.
Clinical and Translational Science|March 17, 2022
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyMichael Boettcher, Gerd Mikus, Dietmar Trenk, et al.
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Pharmacology|April 28, 2025
Effect of the frequently used antiepileptic drugs carbamazepine, gabapentin, and pregabalin on the pharmacokinetics of edoxaban and other oral factor xa inhibitors in healthy volunteersAlexander Lenard, Simon A Hermann, Felicitas Stoll, et al.
Paediatric Drugs|March 18, 2017
Erratum to: Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot StudyJanelle D Vaughns, Victoria C Ziesenitz, Elaine F Williams, et al.
Paediatric Drugs|February 27, 2017
Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot StudyJanelle D Vaughns, Victoria C Ziesenitz, Elaine F Williams, et al.
Clinical Pharmacokinetics|August 1, 2025
Author's Reply to Helsby and Hannam: 'Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights'Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, et al.
British Journal of Clinical Pharmacology|March 18, 2006
Kinetics and dynamics of the peripheral neurokinin-1 receptor antagonist SLV317 in healthy individualsChristiane Hesse, Steffen P Luntz, Heike Siedler, et al.
Drugs & Aging|January 13, 2023
Frailty as a Marker for the Plasma Concentrations of Direct Oral Anticoagulants in Older Patients: Results of an Exploratory StudyAnnette Eidam, Julian Marji, Petra Benzinger, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 19, 2019
Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal filmKlara Kiene, Noriyuki Hayasi, Jürgen Burhenne, et al.
Trials|July 1, 2020
Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trialFelicitas Stoll, Antje Blank, Gerd Mikus, et al.
Clinical Pharmacokinetics|November 21, 2019
Midazolam Pharmacokinetics in Obese and Non-obese Children and AdolescentsChristina Gade, Eva Sverrisdóttir, Kim Dalhoff, et al.
Clinical and Translational Science|March 17, 2022
Vericiguat in combination with isosorbide mononitrate in patients with chronic coronary syndromes: The randomized, phase Ib, VISOR studyMichael Boettcher, Gerd Mikus, Dietmar Trenk, et al.
Pageof 20